| Gliosarcoma studied in …STUDIED_INderived200 of 227show all (up to 200) |
|---|
| → studied in | NCT03896568Phase 1 · recruiting MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07089641Phase 1 · recruiting ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03115333NA · active not recruiting DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Supratentorial Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337686Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095376Phase 3 · active not recruiting Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864534Phase 2 · recruiting Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614855Phase 1 · active not recruiting A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma · condition mapped PROBABILISTIC · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455557Phase 2 · active not recruiting SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555577Phase 1 · active not recruiting Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422363Phase 1 · not yet recruiting Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06806228Phase 1 · suspended Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04477200Phase 1 · active not recruiting Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192359Phase 1 · active not recruiting Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05091866early Phase 1 · terminated Natural Progesterone for the Treatment of Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396860Phase 2/Phase 3 · completed Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04817254Phase 2 · completed Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04528680Phase 1/Phase 2 · active not recruiting Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07134842Phase 1 · recruiting A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment. · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301268Phase 2 · recruiting GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942264Phase 1/Phase 2 · terminated Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756985recruiting Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216329Phase 1 · active not recruiting Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084430Phase 1/Phase 2 · recruiting Study of Pembrolizumab and M032 (NSC 733972) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465954Phase 2 · recruiting Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709226Phase 1 · completed Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746080Phase 2 · completed Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107780Phase 1 · terminated Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01165632early Phase 1 · completed Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01931098Phase 2 · completed Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03137888Phase 2 · completed Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03452930Phase 1 · completed Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430351Phase 1 · terminated Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186509Phase 1 · completed Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01903330Phase 2 · unknown ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01894061Phase 2 · completed NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01814813Phase 2 · terminated Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04397679Phase 1 · terminated Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101905Phase 1 · completed Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03973918Phase 2 · terminated Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00102648Phase 1 · active not recruiting Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01149850Phase 2 · completed Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043391Phase 1 · completed Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02133183Phase 1 · terminated Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02052648Phase 1/Phase 2 · completed Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01922076Phase 1 · completed Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168270Phase 1 · terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01957956early Phase 1 · completed Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658981Phase 1 · completed Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02386826Phase 1 · completed INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360708early Phase 1 · completed Vaccine Therapy in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661282Phase 1/Phase 2 · completed Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662506Phase 1/Phase 2 · completed Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721577Phase 1/Phase 2 · terminated Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02573324Phase 3 · completed A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04091503Phase 1 · completed Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02664363Phase 1 · terminated EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100802Phase 2 · completed Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657315Phase 1/Phase 2 · completed Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311920Phase 1 · completed Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730950Phase 2 · completed Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822275Phase 2 · terminated Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05017610early Phase 1 · withdrawn Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020017early Phase 1 · completed NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00731731Phase 1/Phase 2 · completed Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01062425Phase 2 · completed Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01609790Phase 2 · completed Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669669Phase 1/Phase 2 · terminated O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641326Phase 2 · terminated Sunitinib in Sarcomas of the Central Nervous System · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004874Phase 2 · completed Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856933Phase 2 · completed BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189266Phase 1/Phase 2 · completed Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015819Phase 1 · completed Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020602Phase 1 · completed BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00879437Phase 2 · completed Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01051557Phase 1/Phase 2 · completed Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02798406Phase 2 · completed Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02743078Phase 2 · terminated Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854044Phase 1 · withdrawn ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283631Phase 1 · terminated Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02255461Phase 1 · terminated Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01740258Phase 2 · completed Bevacizumab Beyond Progression (BBP) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031083Phase 1 · completed Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052208Phase 1/Phase 2 · completed Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402116Phase 1/Phase 2 · completed Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03014804Phase 2 · withdrawn Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502708Phase 1 · completed Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498328Phase 2 · completed A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843814NA · terminated Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00035373terminated Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01454596Phase 1/Phase 2 · completed CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514201Phase 1/Phase 2 · completed Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423735Phase 2 · completed Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884741Phase 3 · completed Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337426Phase 1 · completed Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902577Phase 2 · completed MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00441142Phase 1/Phase 2 · completed Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186406Phase 2 · terminated Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734526Phase 1 · terminated Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01977677Phase 1/Phase 2 · completed Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329719Phase 1/Phase 2 · completed Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433381Phase 2 · completed Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01103375Phase 1 · terminated Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01575275Phase 2 · terminated Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01836549Phase 2 · terminated Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03275558Phase 1 · withdrawn Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107003Phase 2 · completed GW572016 to Treat Recurrent Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01086345early Phase 1 · terminated Radiosurgery Plus Bevacizumab in Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234805NA · terminated Yoga Therapy in Treating Patients With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01648348Phase 1/Phase 2 · completed Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234740Phase 1 · completed Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305864Phase 1/Phase 2 · completed Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03401866NA · unknown Multi-site Validation and Application of a Consensus DSC-MRI Protocol · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01480479Phase 3 · completed Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01753713Phase 2 · completed Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172964Phase 1 · completed A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045708Phase 1/Phase 2 · completed A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00187486Phase 2 · completed Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045110Phase 1/Phase 2 · completed Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00980343Phase 2 · completed GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540722Phase 2 · completed Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01975116Phase 1 · completed p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00823797Phase 2 · completed Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112866Phase 2 · terminated Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01122901Phase 2 · terminated Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01996527early Phase 1 · terminated 3T MRI Biomarkers of Glioma Treatment Response · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00379080Phase 1/Phase 2 · completed Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00883298Phase 2 · completed Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967380NA · terminated Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02175745NA · terminated 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459381Phase 2 · completed Pazopanib in Treating Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01250470Phase 1 · completed Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01148966Phase 1 · terminated Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085540Phase 1/Phase 2 · completed FR901228 in Treating Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031965Phase 1 · terminated Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445588Phase 2 · completed Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00995007Phase 2 · completed A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499473Phase 2 · completed Sunitinib in Treating Patients With Recurrent Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085254Phase 1/Phase 2 · completed Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521090Phase 1/Phase 2 · withdrawn EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01189240Phase 1/Phase 2 · terminated RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01113398Phase 2 · completed AMG 102 and Avastin for Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599090Phase 2 · withdrawn Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667394Phase 2 · completed Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369590Phase 2 · completed VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087451Phase 1 · completed Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227434Phase 2 · terminated A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112736Phase 1/Phase 2 · completed Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082926Phase 1 · completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004146Phase 2 · completed Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01122888Phase 1 · terminated Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049387Phase 1 · completed Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979862Phase 1 · completed Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734682Phase 1 · completed A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01131234Phase 1 · completed Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01378481Phase 1 · terminated High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227901Phase 1 · completed Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01124539Phase 2 · unknown Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525525Phase 2 · completed Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884416Phase 1 · completed Sorafenib in Newly Diagnosed High Grade Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00960492Phase 1 · completed Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01380782Phase 2 · completed BIBF 1120 for Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00609999Phase 1 · completed Ph I Dasatinib + Erlotinib in Recurrent MG · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00612989Phase 1 · completed Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02055196Phase 1 · withdrawn Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093613Phase 1 · completed Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00650923Phase 1 · completed Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042991Phase 1/Phase 2 · completed Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095940Phase 1/Phase 2 · completed Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors · condition mapped CURATED_BROADER · 227 trials mapped (31 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238303Phase 2 · completed Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00641706Phase 2 · completed Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00597402Phase 2 · completed Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979017Phase 2 · completed Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00657267Phase 2 · completed Dose-Intense Temozolomide in Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00611325Phase 2 · completed Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00610571Phase 1 · completed Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305656Phase 2 · completed AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00612430Phase 2 · completed Ph II Bevacizumab + Etoposide for Pts w Recurrent MG · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00672243Phase 2 · completed Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039494Phase 2 · completed Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016328Phase 2 · completed CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014170Phase 2 · completed Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00613028Phase 2 · completed Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan · condition mapped ONTOLOGY_EXACT · 227 trials mapped (31 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |